2011Internal Medicine of ChinaRequires access

Efficacy observation of Edaravone combined with Batroxobin in the treatment of acute cerebral infarction

Wei Chen

Open publisher page 0 citations

Abstract

Objective To explore the efficacy of Edaravone combined with Batroxobin in the treatment of acute cerebral infarction.Methods 90 patients with acute cerebral infarction were randomly divided into three groups:Batroxobin group 30 patients,Edaravone group of 30 patients,combination of Batroxobin and Edaravone treatment group 30 patients.The clinical efficacy,neurological deficit scores and changes of fibrinogen levels were compared before and after treatment.Results The effective rate of combination group was 83.3%,significantly higher than Edaravone group(53.3%) and Batroxobin group(50.0%)(P0.05).Neurological deficit scores and fibrinogen levels reduced after treatment(P0.01) in both group.Fibrinogen levels of combination group was significantly lower than that of the other two groups(P0.01).Conclusion In the treatment of acute cerebral infarction,the efficacy of Edaravone combined with Batroxobin was better than single use of edaravone or Batroxobin.

About this research paper

What this paper is about

Objective To explore the efficacy of Edaravone combined with Batroxobin in the treatment of acute cerebral infarction.Methods 90 patients with acute cerebral infarction were randomly divided into three groups:Batroxobin group 30 patients,Edaravone group of 30 patients,combination of Batroxobin and Edaravone treatment group 30 patients.The clinical efficacy,neurological deficit scores and changes of fibrinogen levels were compared before and after treatment.Results The effective rate of combination group was 83.3%,significantly higher than Edaravone group(53.3%) and Batroxobin group(50.0%)(P0.05).Neurological deficit scores and fibrinogen levels reduced after treatment(P0.01) in both group.Fibrinogen levels of combination group was significantly lower than that of the other two groups(P0.01).Conclusion In the treatment of acute cerebral infarction,the efficacy of Edaravone combined with Batroxobin was better than single use of edaravone or Batroxobin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the efficacy of Edaravone combined with Batroxobin in the treatment of acute cerebral infarction.Methods 90 patients with acute cerebral infarction were randomly divided into three groups:Batroxobin group 30 patients,Edaravone group of 30 patients,combination of Batroxobin and Edaravone treatment group 30 patients.The clinical efficacy,neurological deficit scores and changes of fibrinogen levels were compared before and after treatment.Results The effective rate of combination group was 83.3%,significantly higher than Edaravone group(53.3%) and Batroxobin group(50.0%)(P0.05).Neurological deficit scores and fibrinogen levels reduced after treatment(P0.01) in both group.Fibrinogen levels of combination group was significantly lower than that of the other two groups(P0.01).Conclusion In the treatment of acute cerebral infarction,the efficacy of Edaravone combined with Batroxobin was better than single use of edaravone or Batroxobin.

Key concepts: Batroxobin, Edaravone, Medicine, Fibrinogen, Cerebral infarction, Anesthesia, Clinical efficacy, Neurological deficit

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy observation of Edaravone combined with Batroxobin in the treatment of acute cerebral infarction — Research Paper | ScholarLens